cadmium telluride has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dou, NN; Gao, G; Liu, MX; Visocchi, M; Zhong, J | 1 |
| Juzenas, P; Kavaliauskiene, S; Purviniene, R; Rotomskis, R; Steponkiene, S | 1 |
2 other study(ies) available for cadmium telluride and Astrocytoma, Grade IV
| Article | Year |
|---|---|
One-Pot Aqueous Synthesization of Near-Infrared Quantum Dots for Bioimaging and Photodynamic Therapy of Gliomas.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Brain Neoplasms; Cadmium Compounds; Cell Line, Tumor; Cell Survival; Glioblastoma; Glioma; Humans; In Vitro Techniques; Low-Level Light Therapy; Mice; Microscopy, Confocal; Oligopeptides; Photochemotherapy; Quantum Dots; Tellurium | 2017 |
Quantum dots affect expression of CD133 surface antigen in melanoma cells.
Topics: 3-Mercaptopropionic Acid; AC133 Antigen; Antigens, CD; Biomarkers, Tumor; Cadmium Compounds; Cell Line, Tumor; Cell Survival; Flow Cytometry; Glioblastoma; Glycoproteins; Humans; Hyaluronan Receptors; Male; Melanoma; Neoplastic Stem Cells; Pancreatic Neoplasms; Peptides; Phenotype; Prostatic Neoplasms; Quantum Dots; Tellurium | 2011 |